
Formulary Search
You are here : Home > Formulary Search
A to Z of Drugs : D
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key



Status Key
- Capsules
- Capsules
- Capsules
- Sachets (granules)
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
- Tablets
- Oral drops
On advice from specialist
NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g. Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency
- Infusion
- Subcutaneous injection (sc)
- Subcutaneous injection (sc)
- Subcutaneous injection (sc)
- Subcutaneous injection (sc)
- Subcutaneous injection (sc)
- Injection
- Intravenous injection (IV)
- Intravenous injection (IV)
- Intravenous injection (IV)
- Capsules
- Injection
- Tablets
- Tablets
- Tablets
- Tablets
- Tablets
- Tablets
- Infusion
- Intravenous injection (IV)
- Subcutaneous injection (sc)
Heamatology team only.
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts.
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
- Tablets
On recommendation from specialist sleep clinics (locally at RSFT/QVH) only.
- Not Specified
- Suspension
- Tablets
- Tablets
- Tablets
- Tablets
For Transfusion-related iron overload.
Not for use in thalassemia or sickle cell - NHSE commissioned services only.
- Not Specified
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Only licensed for the NHSE commissioned indications. Therefore, not for use in Surrey Heartlands Trusts
- Not Specified
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
- Subcutaneous injection (sc)
Initiation and 1st month supply by the specialist team before any request for primary care prescribing.
- Capsules
ONLY after post single anastomosis duodenal illeal bypass with sleeve (SADI-S) or duodenal switch surgery.
Prescribing by primary care on recommendation from specialist team.
- Not Specified
- Tablets
- Cream
Not assessed for inclusion on the formulary. NICE guidance is anticipated in Aug 25. Advice will be updated post-NICE.
- Capsules
- Tablets
- Capsules
Initiation and stabilisation by the specialist team for a minimum of 3 months before any request for primary care prescribing.
- Subcutaneous injection (sc)
Biosimilar - prescribe by brand.
- Subcutaneous injection (sc)
Rheumatology only in secondary care.
Restricted to use in patients for whom bisphosphonates are unsuitable.
- Intravenous infusion
- Subcutaneous injection (sc)
For Transfusion-related iron overload.
Not for use in thalassemia or sickle cell - NHSE commissioned services only.
- Not Specified
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
- Tablets
- Oral solution
- Tablets
Prescribe generically.
Initiation in Primary Care on recommendation from the specialist team.
- Sublingual tablets
Prescribe generically.
Initiation in Primary Care on recommendation from the specialist team.
- Oral lyophilisates
Note - In Primary Care, sublingual tablets are lower cost than oral lyophilisates. Consider the use of sublingual tablets if appropriate.
Initiation in Primary Care on recommendation from the specialist team.
- Nasal spray
10mcg nasal spray.
Initiation in Primary Care on recommendation from the specialist team.
- Injection
4mcg/ml injection.
- Injection
For haemophilic / von Willebrand patients undergoing surgery / following trauma.
Available as:
4mcg/ml (DDAVP)
15mcg/ml (Octim) - much more expensive. Useful when lower volume is required
- Tablets
Initiation in Primary Care on recommendation from the specialist paediatric team.
Prescribe generically.
- Sublingual tablets
Initiation in Primary Care on recommendation from the specialist paediatric team.
Prescribe generically.
- Oral lyophilisates
Initiation in Primary Care on recommendation from the specialist paediatric team.
Note - In Primary Care, sublingual tablets are lower cost than oral lyophilisates. Consider the use of sublingual tablets if appropriate.
- Oral lyophilisates
Initiation and 1 month supply by the specialist before any request for primary care prescribing.
Women - 25mcg dose
Men - 50mcg dose
- Tablets
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Prescribe generically - not to be prescribed by brand.
12 hour missed pill window with higher risk of irregular bleeding
Option for endometriosis
- Not Specified
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Desorex, Zelletta, Feanolla, Cerelle, Desomono, Cerazette, Lovima -Do NOT prescribe by brand
- Tablets
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
On recommendation of palliative care team
- Tablets
- Oral solution
- Injection
- Tablets
Recommended in NICE NG191
- Intravitreal implant
- Eye drops
- Eye drops (preservative free
- unit dose)
- Oral solution
- Tablets
- Injection
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
On advice from palliative care specialist team.
- Oral solution
- Tablets
- Injection
- Injection
- Tablets
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
On recommendation of palliative care team
- Subconjunctival injection
- Intravitreal implant
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
On advice from palliative care specialist team.
- Intravitreal implant
- Intra-articular injection
- Ear drops
- Spray
- Eye drops
- Eye ointment
- Eye drops
- Tablets
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
- Tablets
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
- Tablets
RSFT only
- Oral solution
- Oral suspension
- Powder
Prescribe on advice from specialist e.g. dietitian
- Not Specified
- Injection
- Enema
- Tablets
- Oral solution
- Tablets
- Injection
- Rectal solution
- Injection
- Oral solution
Paediatric use.
Always used in combination with chlorothiazide.
- Capsules
Unlicensed product
- Tablets
- Oral suspension
- Gel
- Suppositories
- Injection
- Tablets
- Modified release capsules
- Modified release tablets
- Eye drops
- Eye drops (preservative free
- unit dose)
- Not Specified
- Dispersible tablets
- Tablets
- Not Specified
To be initiated and first 6 months treatment to be supplied by a specialist
- Tablets
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Not recommended for new initiations. Existing patients may remain on this brand.
- Tablets
Initiation and 1st month supply by the specialist team before any request for primary care prescribing.
- Elixir
- Tablets
- Injection
- Oral solution
- Tablets
- Intravenous infusion
- Oral solution
- Tablets
- Modified release tablets
- Cream
- Ointment
- Modified release tablets
- Modified release capsules
- Modified release tablets
- Modified release capsules
- Capsules
Relapsing-remitting multiple sclerosis
- Not Specified
- Injection
- Pessaries
- Vaginal gel
- Intravenous infusion
- Oral solution
- Tablets
- Subcutaneous injection (sc)
- Modified release capsules
Not 1st-line. Alternative to clopidogrel and aspirin
- Modified release capsules
- Oral suspension
- Tablets
- Capsules
Relapsing-remitting multiple sclerosis
- Sachets
- Sachets
- Sachets
- Eye drops
- Capsules
- Modified release tablets
- Intravenous infusion
Inotropic support and shock.
- Capsules
- Oral solution
- Enema
- Ear drops
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Oral suspension
- Tablets
- Tablets
- Intravenous infusion
This drug has not yet been assessed for formulary status.
If a patient is accessing non-NHS supplies of this medication, refer to the NHSE information here (for a similar drug called lecanemab) which provides advice on potential adverse effects.
- Not Specified
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
- Not Specified
- Intravenous infusion
Cardiogenic shock
- Nebules
- Nebules
For intrapleural use.
- Eye drops
- Eye drops
- Eye drops (preservative free
- unit dose)
- Not Specified
- Injection
- Immediate release tablets
- Modified release tablets
- Immediate release tablets
- Modified release tablets
- Capsules
- Dispersible tablets
- Tablets
- Injection
- Gastro-resistant tablets
- Tablets
- Injection
- Tablets
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
- Tablets
- Tablets
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
Not recommended for new initiations. Existing patients may remain on this brand.
- Not Specified
- Subcutaneous injection (sc)
- Capsules
- Powder
Prescribe on advice from specialist e.g. dietitian
- Not Specified
- Subcutaneous injection (sc)
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
- Subcutaneous injection (sc)
- Capsules